Benzquinamide is a discontinued antiemetic compound with antihistaminic, mild anticholinergic, and sedative properties. The mechanism of action is not known, but presumably benzquinamide works via antagonism of muscarinic acetycholine receptors and histamine H1 receptors.
Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Aclidinium | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Aclidinium. |
| Mianserin | Mianserin may increase the anticholinergic activities of Benzquinamide. |
| Mirabegron | The risk or severity of urinary retention can be increased when Benzquinamide is combined with Mirabegron. |
| Potassium chloride | The risk or severity of gastrointestinal ulceration can be increased when Benzquinamide is combined with Potassium chloride. |
| Pramlintide | The risk or severity of reduced gastrointestinal motility can be increased when Pramlintide is combined with Benzquinamide. |
| Secretin porcine | The therapeutic efficacy of Secretin porcine can be decreased when used in combination with Benzquinamide. |
| Tiotropium | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Tiotropium. |
| Topiramate | The risk or severity of hyperthermia and oligohydrosis can be increased when Benzquinamide is combined with Topiramate. |
| Umeclidinium | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Umeclidinium. |
| Benzylpenicilloyl polylysine | Benzquinamide may decrease effectiveness of Benzylpenicilloyl polylysine as a diagnostic agent. |
| Betahistine | The therapeutic efficacy of Betahistine can be decreased when used in combination with Benzquinamide. |
| Hyaluronidase (ovine) | The therapeutic efficacy of Hyaluronidase (ovine) can be decreased when used in combination with Benzquinamide. |
| Hyaluronidase (human recombinant) | The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Benzquinamide. |
| Hyaluronidase | The therapeutic efficacy of Hyaluronidase can be decreased when used in combination with Benzquinamide. |
| Glycopyrronium | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Glycopyrronium. |
| Botulinum toxin type A | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Botulinum toxin type A. |
| Glucagon | Benzquinamide may increase the gastrointestinal motility reducing activities of Glucagon. |
| Sulpiride | Benzquinamide may increase the anticholinergic activities of Sulpiride. |
| Botulinum toxin type B | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Botulinum toxin type B. |
| Eluxadoline | The risk or severity of constipation can be increased when Benzquinamide is combined with Eluxadoline. |
| Ramosetron | The risk or severity of constipation can be increased when Benzquinamide is combined with Ramosetron. |
| Amphetamine | Amphetamine may decrease the sedative activities of Benzquinamide. |
| Phentermine | Phentermine may decrease the sedative activities of Benzquinamide. |
| Pseudoephedrine | Pseudoephedrine may decrease the sedative activities of Benzquinamide. |
| Benzphetamine | Benzphetamine may decrease the sedative activities of Benzquinamide. |
| Diethylpropion | Diethylpropion may decrease the sedative activities of Benzquinamide. |
| Lisdexamfetamine | Lisdexamfetamine may decrease the sedative activities of Benzquinamide. |
| Mephentermine | Mephentermine may decrease the sedative activities of Benzquinamide. |
| MMDA | MMDA may decrease the sedative activities of Benzquinamide. |
| Midomafetamine | Midomafetamine may decrease the sedative activities of Benzquinamide. |
| 2,5-Dimethoxy-4-ethylamphetamine | 2,5-Dimethoxy-4-ethylamphetamine may decrease the sedative activities of Benzquinamide. |
| 4-Bromo-2,5-dimethoxyamphetamine | 4-Bromo-2,5-dimethoxyamphetamine may decrease the sedative activities of Benzquinamide. |
| Tenamfetamine | Tenamfetamine may decrease the sedative activities of Benzquinamide. |
| Chlorphentermine | Chlorphentermine may decrease the sedative activities of Benzquinamide. |
| Methylenedioxyethamphetamine | Methylenedioxyethamphetamine may decrease the sedative activities of Benzquinamide. |
| Dextroamphetamine | Dextroamphetamine may decrease the sedative activities of Benzquinamide. |
| Metamfetamine | Metamfetamine may decrease the sedative activities of Benzquinamide. |
| Iofetamine I-123 | Iofetamine I-123 may decrease the sedative activities of Benzquinamide. |
| Ritobegron | Ritobegron may decrease the sedative activities of Benzquinamide. |
| Mephedrone | Mephedrone may decrease the sedative activities of Benzquinamide. |
| Methoxyphenamine | Methoxyphenamine may decrease the sedative activities of Benzquinamide. |
| Gepefrine | Gepefrine may decrease the sedative activities of Benzquinamide. |
| 2,5-Dimethoxy-4-ethylthioamphetamine | 2,5-Dimethoxy-4-ethylthioamphetamine may decrease the sedative activities of Benzquinamide. |
| Phendimetrazine | Phendimetrazine may decrease the sedative activities of Benzquinamide. |
| Naltrexone | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Naltrexone. |
| Bezitramide | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Bezitramide. |
| Tramadol | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Tramadol. |
| Codeine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Codeine. |
| Hydromorphone | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Hydromorphone. |
| Methadone | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Methadone. |
| Meperidine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Meperidine. |
| Oxycodone | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Oxycodone. |
| Butorphanol | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Butorphanol. |
| Dextropropoxyphene | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Dextropropoxyphene. |
| Sufentanil | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Sufentanil. |
| Alfentanil | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Alfentanil. |
| Fentanyl | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Fentanyl. |
| Nalbuphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Nalbuphine. |
| Levorphanol | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Levorphanol. |
| Remifentanil | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Remifentanil. |
| Buprenorphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Buprenorphine. |
| Hydrocodone | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Hydrocodone. |
| Diphenoxylate | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Diphenoxylate. |
| Oxymorphone | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Oxymorphone. |
| Dezocine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Dezocine. |
| Levacetylmethadol | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Levacetylmethadol. |
| Methadyl acetate | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Methadyl acetate. |
| Dihydroetorphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Dihydroetorphine. |
| Diamorphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Diamorphine. |
| Ethylmorphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Ethylmorphine. |
| Etorphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Etorphine. |
| Dextromoramide | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Dextromoramide. |
| Desomorphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Desomorphine. |
| Carfentanil | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Carfentanil. |
| Dihydrocodeine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Dihydrocodeine. |
| Alphacetylmethadol | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Alphacetylmethadol. |
| Dihydromorphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Dihydromorphine. |
| Tapentadol | The risk or severity of urinary retention and constipation can be increased when Benzquinamide is combined with Tapentadol. |
| Ketobemidone | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Ketobemidone. |
| DPDPE | The risk or severity of adverse effects can be increased when Benzquinamide is combined with DPDPE. |
| Lofentanil | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Lofentanil. |
| Opium | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Opium. |
| Normethadone | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Normethadone. |
| Piritramide | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Piritramide. |
| Alphaprodine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Alphaprodine. |
| Nicomorphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Nicomorphine. |
| Meptazinol | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Meptazinol. |
| Phenoperidine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Phenoperidine. |
| Phenazocine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Phenazocine. |
| Tilidine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Tilidine. |
| Carfentanil, C-11 | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Carfentanil, C-11. |
| Morphine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Morphine. |
| Pentazocine | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Pentazocine. |
| Benzhydrocodone | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Benzhydrocodone. |
| Naloxegol | The risk or severity of adverse effects can be increased when Benzquinamide is combined with Naloxegol. |
| Trospium | The risk or severity of adverse effects can be increased when Trospium is combined with Benzquinamide. |
| Oxyphenonium | The risk or severity of adverse effects can be increased when Oxyphenonium is combined with Benzquinamide. |
| Benzatropine | The risk or severity of adverse effects can be increased when Benzatropine is combined with Benzquinamide. |
| Disopyramide | The risk or severity of adverse effects can be increased when Disopyramide is combined with Benzquinamide. |
| Metixene | The risk or severity of adverse effects can be increased when Metixene is combined with Benzquinamide. |